The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
Ravi Salgia(City Of Hope National Medical Center), James D. Griffin(Harvard University), Kevin Klucher(Harvard University), Martin Sattler(Harvard University), Natalia Souchkova(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Ulrich H. von Andrian(Harvard University), Ann Marie Pendergast(Duke University), George Q. Daley(Boston Children's Hospital), Elizabeth J. Quackenbush(Harvard University), Darren S. Ewaniuk(Harvard University), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert Sackstein(Florida International University), S K Kraeft(Harvard University), José-Carlos Gutierrez-Ramos(Harvard University), Lan Bo Chen(Harvard University), Jeffrey Lin(The University of Texas Health Science Center at Houston)
Cited by 83
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k